Back to Results

Implementing a pharmacist-led protocol to survey and follow-up people living with HIV taking Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) single tablet regimen after being switched from two tablet regimen of Dolutegravir plus Emtricitabine/Tenofovir Alafenamide (DTG + FTC/TAF): patients' satisfaction and adherence

Study category: Infectious Diseases

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Type of Study

Other

Location

University of Colorado Hospital

Principal Investigator
Jasjit Gill

Jasjit Gill

Study ID

Protocol Number: 18-0715

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers